AQUESTIVE THERAPEUTICSCS INC
AQUESTIVE THERAPEUTICSCS INC
Aktie · US03843E1047 · AQST (XNAS)
Übersicht Finanzkennzahlen
3,44 USD
1,76 % 0,06 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
16.06.2025 22:37

Aktuelle Kurse von AQUESTIVE THERAPEUTICSCS INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
AQST
USD
16.06.2025 22:37
3,44 USD
3,42 USD
+0,59 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
1,76 % -6,26 % 43,64 % 20,92 % -4,97 % 27,88 % -33,84 %

Profil de l'entreprise pour AQUESTIVE THERAPEUTICSCS INC Action

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.

Données de l'entreprise

Nom AQUESTIVE THERAPEUTICSCS INC
Société Aquestive Therapeutics, Inc.
Symbole AQST
Site web https://www.aquestive.com
Marché d'origine XNAS NASDAQ
ISIN US03843E1047
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - Specialty & Generic
PDG Mr. Daniel Barber
Capitalisation boursière 253 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 30 Technology Drive, 07059 Warren
Date d'introduction en bourse 2018-07-25

Symboles boursiers

Nom Symbole
NASDAQ AQST

Autres actions

Les investisseurs qui détiennent AQUESTIVE THERAPEUTICSCS INC ont également les actions suivantes dans leur portefeuille :
NATL WESTM. BK 17/24 MTN
NATL WESTM. BK 17/24 MTN Obligation
TRIPADVISOR INC
TRIPADVISOR INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025